[Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
Liebau
H
H
Wurst
W
W
Harder
I
I
Solleder
P
P
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies
D000959:Antihypertensive Agents; D001786:Blood Glucose; D008055:Lipids; D010879:Piperazines; C015568:urapidil
Stoffwechselneutrale Hochdrucktherapie. Offene, multizentrische, prospektive Langzeitprüfung von Verträglichkeit, Sicherheit und Wirksamkeit von Urapidil.